- 35.6k views
Critical Care Procedures Done in COVID ICU
Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.
About the Speaker
Dr. Aklesh Tandekar
CRITICAL CARE SPECIALIST MD, EDIC, IDCCM, FIMSA, DA, FCPS, FISCCM
Watch Next
Case Discussion on Acute Coronary Syndrome
Acute Coronary Syndrome (ACS) is a term used to describe a group of potentially life-threatening conditions related to the heart and blood vessels. ACS encompasses a spectrum of cardiac emergencies, including unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI). The hallmark of ACS is inadequate blood supply to the heart muscle due to partial or complete blockage of coronary arteries, often caused by atherosclerosis or blood clot formation. STEMI, the most severe form of ACS, is characterized by ST-segment elevation on an electrocardiogram and demands immediate reperfusion therapy, such as angioplasty or thrombolytic drugs, to restore blood flow to the affected area. NSTEMI and unstable angina are also serious conditions requiring medical attention. NSTEMI involves elevated cardiac biomarkers but no ST-segment elevation, while unstable angina presents with chest pain at rest or with minimal exertion and no biomarker elevation.
Sepsis: Early Recognition and Management
Sepsis is a life-threatening condition that demands early recognition and prompt management. It typically arises as the body's extreme response to an infection, and its progression can be rapid. Early recognition involves identifying signs such as fever, rapid heart rate, and altered mental state. Once suspected, immediate medical attention is crucial. Management often requires antibiotics, intravenous fluids, and, in severe cases, admission to an intensive care unit for close monitoring and supportive care. Early intervention is vital in sepsis to prevent it from advancing to severe septic shock, which has a higher mortality rate. Hence, sepsis demands swift recognition and timely medical intervention for the best possible outcomes.
Oxygen Therapy : All you need to know
Oxygen therapy is a medical intervention that involves the administration of oxygen at a higher concentration than what is present in ambient air to patients with respiratory or cardiovascular conditions. It is delivered through various methods, including nasal cannulas, oxygen masks, or ventilators, to improve oxygen saturation in the blood. Oxygen therapy is crucial in managing conditions like chronic obstructive pulmonary disease (COPD), pneumonia, and severe respiratory distress, helping patients breathe more comfortably and ensuring adequate oxygen supply to vital organs. Treatment duration and oxygen flow rates are tailored to individual patient needs, and close monitoring is essential to optimize therapy effectiveness while avoiding potential complications associated with excessive oxygen levels.
Management of Stroke in ICU
Rapid transfer of stroke patients to the ICU allows for immediate assessment and intervention.Continuous monitoring of vital signs, neurological status, and oxygen saturation is essential to detect changes promptly. Administration of clot-dissolving agents like tissue plasminogen activator (tPA) within the therapeutic window can restore blood flow in ischemic stroke patients. For large vessel occlusion, mechanical removal of the clot using catheter-based techniques can be performed in eligible patients. Maintain stable blood pressure and perfusion to the brain while avoiding extremes that might exacerbate cerebral edema or hemorrhage. Ensure proper airway management and oxygenation to prevent secondary brain injury. Frequent imaging (CT or MRI) monitors for changes in brain structure, blood flow, and response to treatment. Continuous ICP monitoring helps manage elevated pressure and prevent cerebral herniation.
Optimizing Antibiotic Therapy in the critically ill Patients
Optimizing antibiotic therapy in critically ill patients is a crucial aspect of modern healthcare. Critically ill patients often face severe infections, and appropriate antibiotic treatment can significantly impact their outcomes. However, due to various factors such as altered pharmacokinetics, drug interactions, and the emergence of antibiotic-resistant pathogens, selecting the right antibiotic regimen can be challenging. This short intro explores the importance of tailoring antibiotic therapy to individual patients, considering the severity of their condition, microbiological data, and the prudent use of antibiotics to achieve optimal outcomes in critically ill settings.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Aklesh Tandekar's Talks on Assimilate
- 0
Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.
- 0
Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.
- 0
Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.